⌘K
Loading ticker…
As of 2026-08-24, Adicet Bio, Inc. Common Stock (ACET) has a 3-month relative strength percentile of 62 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.3%, relative volume 0.76×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ACET appears in 1 ETF as of Apr 2026: DFAS at 0.00% weight, $71K notional.
Held by 3 ETFs · $2M across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DFASDimensional U.S. Small Cap ETF | 0.00% | $71K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ACET Jan avg: 11.86% median: -1.38% win: 50% σ: 31.20% n: 4 2022-04-12 → 2026-07-31 | ACET Feb avg: -10.75% median: -11.57% win: 25% σ: 9.61% n: 4 2022-04-12 → 2026-07-31 | ACET Mar avg: -12.24% median: -11.03% win: 0% σ: 11.79% n: 4 2022-04-12 → 2026-07-31 | ACET Apr avg: -10.56% median: -12.31% win: 40% σ: 18.13% n: 5 2022-04-12 → 2026-07-31 | ACET May avg: 0.63% median: -2.69% win: 40% σ: 16.21% n: 5 2022-04-12 → 2026-07-31 | ACET Jun avg: -14.19% median: -15.08% win: 20% σ: 28.27% n: 5 2022-04-12 → 2026-07-31 | ACET Jul avg: 13.64% median: 12.39% win: 100% σ: 7.27% n: 5 2022-04-12 → 2026-07-31 | ACET Aug avg: -9.89% median: -9.74% win: 25% σ: 13.37% n: 4 2022-04-12 → 2026-07-31 (current) | ACET Sep avg: -4.98% median: -0.47% win: 50% σ: 18.73% n: 4 2022-04-12 → 2026-07-31 | ACET Oct avg: -1.56% median: -5.54% win: 25% σ: 12.07% n: 4 2022-04-12 → 2026-07-31 | ACET Nov avg: -6.41% median: -11.16% win: 25% σ: 11.18% n: 4 2022-04-12 → 2026-07-31 | ACET Dec avg: -6.08% median: -16.84% win: 25% σ: 47.01% n: 4 2022-04-12 → 2026-07-31 |